作者: Michael Ochse , Wolfgang Wernet , Wilhelm Amberg , Astrid Netz , Charles W. Hutchins
DOI:
关键词:
摘要: The invention relates to the hetaryl-substituted guanidine compounds of general formula (I), enantiomeres, diastereomeres and/or tautomeres thereof, in addition pharmaceutically acceptable salts thereof and prodrugs known compounds. also use said as binding partners for 5-HT5-receptors treating prophylaxis illnesses which are modulated by a 5-HT5-receptor activity, particular, neurodegenerative neuropsychiatric disorders, signs, symptoms dysfunctions associated with disorders.